Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan diseases.
View all
TRICIDA
Post IPO Equity • South San Francisco, United States
Catalyst Pharmaceuticals
Post IPO Equity • Coral Gables, United States
Spectrum Pharmaceuticals
Post IPO Equity • Henderson, United States
DURECT
Post IPO Equity • Cupertino, United States
Insys Therapeutics
Post IPO Equity • Phoenix, United States
Alimera Sciences
Post IPO Equity • Alpharetta, United States
Adamas Pharmaceuticals
Post IPO Equity • Emeryville, United States
OncoSec
Post IPO Equity • San Diego, United States
Satellogic
Post IPO Equity • Palo Alto, United States
Allurion
Venture • Wellesley, United States
Rigetti Computing
Post IPO Equity • Berkeley, United States
IsoPlexis
Post IPO Equity • Branford, United States